Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding
Open Access
- 1 April 2004
- journal article
- hiv
- Published by BMJ in Sexually Transmitted Infections
- Vol. 80 (2) , 108-112
- https://doi.org/10.1136/sti.2003.005157
Abstract
Objectives: To link local proinflammatory cytokines with HIV related nucleic acids in cervico-vaginal secretions and the factors associated with them. Methods: An observational study on 60 HIV positive women attending the department of obstetrics and gynaecology, University of Pavia, Italy. HIV-1 RNA in plasma, proviral HIV-1-DNA, cell associated and cell free HIV-1 RNA in cervico-vaginal secretions were evaluated by competitive polymerase chain reaction (c-PCR) and reverse transcriptase PCR (cRT-PCR). IL-1β, IL-6, and TNF-α were measured by ELISA in cervico-vaginal lavages. Multiple regression analysis on ordinal categorical variables was used to test for the simultaneous associations of clinical and microbiological variables on quartiles of cytokine concentrations in lavage samples. Results: Proviral HIV-1 DNA, cell associated and cell free HIV-1 RNA were detected in 76.7% (46/60), 70% (42/60), and 71.7% (43/60) of the patients, respectively. IL-1β concentration was directly correlated with proviral HIV-DNA (Spearman rho = 0.35, p = 0.01) and cell associated HIV-RNA levels (Spearman rho = 0.263, p = 0.05). IL-1β concentration (153.9 pg/ml) was higher (pConclusions: Local immune activation may modulate HIV-1 shedding in cervico-vaginal secretion with possible influence on vaginal physiology and host defence. Pharmacological agents lowering HIV-1 replication cause a shift to a pattern of cytokine production which seems less favourable to the transmission of the disease.Keywords
This publication has 24 references indexed in Scilit:
- A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma sheddingAIDS, 2001
- Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.European Journal of Clinical Microbiology & Infectious Diseases, 2001
- Correlation between Human Immunodeficiency Virus Type 1 RNA Levels in the Female Genital Tract and Immune Activation Associated with Ulceration of the CervixThe Journal of Infectious Diseases, 2000
- Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNAAIDS, 2000
- Quantitative assessment of cell-associated and cell-free virus in cervicovaginal samples of HIV-1-infected womenClinical Microbiology & Infection, 1999
- Cervical Human Immunodeficiency Virus Type 1 Shedding Is Associated with Genital β‐Chemokine SecretionThe Journal of Infectious Diseases, 1998
- Cytokine modulation of HIV expressionSeminars in Immunology, 1993
- The Effect of Cytokines and Pharmacologic Agents on Chronic HIV InfectionAIDS Research and Human Retroviruses, 1992
- CORRELATIONS AND INTERACTIONS IN THE PRODUCTION OF INTERLEUKIN-6 (IL-6), IL-1, AND TUMOR NECROSIS FACTOR (TNF) IN HUMAN-BLOOD MONONUCLEAR-CELLS - IL-6 SUPPRESSES IL-1 AND TNF1990
- Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associationsPublished by Elsevier ,1983